Legal Representation
Attorney
Richard A. Zachar
USPTO Deadlines
Next Deadline
1725 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2010-03-30)
Due Date
March 30, 2030
Grace Period Ends
September 30, 2030
Application History
25 eventsDate | Code | Type | Description |
---|---|---|---|
Nov 4, 2016 | C8.. | O | CANCELLED SEC. 8 (6-YR) |
Apr 6, 2011 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Mar 30, 2010 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Feb 25, 2010 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED |
Feb 24, 2010 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Feb 24, 2010 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Feb 24, 2010 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Dec 30, 2009 | FAXX | I | FAX RECEIVED |
Dec 30, 2009 | IUAF | S | USE AMENDMENT FILED |
Jul 21, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Apr 28, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION |
Apr 8, 2009 | NPUB | O | NOTICE OF PUBLICATION |
Mar 20, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Mar 20, 2009 | ALIE | A | ASSIGNED TO LIE |
Mar 20, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Mar 19, 2009 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Mar 19, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Mar 19, 2009 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Mar 19, 2009 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED |
Nov 18, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN |
Nov 18, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED |
Nov 18, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Nov 17, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
Aug 12, 2008 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED |
Aug 11, 2008 | NWAP | I | NEW APPLICATION ENTERED |
Additional Information
Design Mark
The mark consists of the word "Gynecologic" with the second letter "g" having a design incorporating the female gender symbol with the words "cancer collaborative" on the next line.
Color Claim
Color is not claimed as a feature of the mark.
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"GYNECOLOGIC CANCER COLLABORATIVE"